Vistin Pharma ASA: New CEO appointed

Oslo, Norway, 25th of October 2023

The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1^st of January 2024. Magnus Tolleshaug is currently the CCO in Vistin Pharma, and will replace the current CEO, Kjell-Erik Nordby. Kjell-Erik has been the CEO of Vistin Pharma since the company was established in 2015 and has decided to retire. Magnus started his career in Vistin 1^st of March 2020 and has been instrumental in delivering Vistin’s ambitious growth strategy. Before Magnus joined Vistin, he worked for many years in Takeda Pharmaceuticals as «Head of Global Launch Excellence & Product Lifecycle Management». Magnus has more than 20 years of experience from the global pharmaceutical industry and various international leadership roles.

During Kjell-Erik’s leadership Vistin’s Metformin business has seen more than 300% revenue growth and he has been essential in transforming Vistin into a well-recognized world leading Metformin producer.

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.